Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy

Gang Li; Jieping Hu; Yuanjie Niu

doi:10.18632/oncotarget.18563

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy

Gang Li, Jieping Hu and Yuanjie Niu _

PDF | HTML | How to cite

Oncotarget. 2018; 9:217-223. https://doi.org/10.18632/oncotarget.18563

Metrics: PDF 1309 views | HTML 2760 views | ?

Abstract

Gang Li1,*, Jieping Hu2,* and Yuanjie Niu1

1Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin, 300211, China

2Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China

*These authors contributed equally to this work

Correspondence to:

Yuanjie Niu, email: [email protected]

Keywords: squamous differentiation, pT1, bladder cancer, urothelial carcinoma, intravesical chemotherapy

Received: October 31, 2016 Accepted: June 02, 2017 Published: June 19, 2017

ABSTRACT

The role of squamous differentiation in pT1 bladder tumors in the response to intravesical chemotherapy was unknown. We performed a retrospective analysis of 213 pT1 bladder urothelial carcinoma patients with squamous differentiation (group1), the remaining 213 pT1 pure urothelial carcinoma served as controls (group2). All cases were treated with transurethral resection of bladder tumor and subsequent intravesical chemotherapy. Within a five-year period, the tumor recurrence rate was 75.1% (160/213) in group 1 and 64.3% (137/213) in group 2. Tumor grade (HR = 2.926, P = 0.014), number of tumors (HR = 2.130, P = 0.038), tumor size (HR = 2.748, P = 0.031), and squamous differentiation (HR = 3.726, P = 0.019) were found to be important prognostic factors. Subgroup analysis for high grade tumors was performed, finding that group 1 had higher recurrence rate (50.3% vs 36.3%; for group 2). Progression was found in 32.2% (30/160) of group1 and 15.1% (11/137) of group2 (P = 0.011). Our data suggests that squamous differentiation is a predictor of poor response for intravesical chemotherapy, and that early radical cystectomy should be performed for high grade tumors, especially when dealing with recurrent cases.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18563

Publication Alerts

Research Papers:

Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy

Abstract